Literature DB >> 7527324

Pharmacological management of back pain syndromes.

R W Porter1, S H Ralston.   

Abstract

The symptom of back pain may be the result of many different pathologies. As such, patients with back pain require careful assessment to determine whether the cause is from the spine or other systems. For acute mechanical back pain, treatment is often symptomatic. Symptomatic treatment may include analgesics, anti-inflammatories and/or muscle relaxants. Patients may also need hypnotics in the short term to help them sleep at night. However, drug therapy should be reduced and stopped as soon as possible. Furthermore, too much bedrest may be counterproductive. Paracetamol (acetaminophen) is the standard treatment for transient back pain. More severe pain may require the addition of an opioid, such as codeine or dextropropoxyphene. Morphine and pethidine (meperidine) may be necessary in patients with back pain due to neoplastic disease or osteoporotic fracture. However, the opioid analgesics are associated with dependence, tolerance and adverse effects. Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic efficacy comparable with paracetamol. Individual patients respond differently to different NSAIDs, and several agents may have to be tried. Long term therapy with NSAIDs is necessary in diseases with an inflammatory component such as ankylosing spondylitis. Calcitonin reduces bone resorption and bone blood flow, and has been suggested to have central analgesic effects. As such, it has been used successfully in patients with Paget's disease, osteolytic bone disease and osteoporosis. Bisphosphonates also inhibit osteoclastic bone resorption and may be useful in Paget's disease, osteolytic metastases and osteoporotic fractures. Other drugs which may be useful in relieving back pain associated with specific circumstances include the tricyclic antidepressants, anxiolytics, antiepileptic agents, corticosteroids, colchicine and chymopapain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527324     DOI: 10.2165/00003495-199448020-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  27 in total

1.  Low-dose, low-volume chemonucleolysis. A biochemical study.

Authors:  P M Dando; J R Jenner; A Charles; D J Buttle
Journal:  Spine (Phila Pa 1976)       Date:  1992-01       Impact factor: 3.468

2.  Calcitonin for pseudoclaudication in lumbar spinal stenosis.

Authors:  J Streifler; R Hering; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

3.  Actions of calcitonin and mithramycin.

Authors:  T J Martin
Journal:  Arthritis Rheum       Date:  1980-10

4.  Comparison of the effect of diazepam and levomepromazine on pain in patients with acute lumbago-sciatica.

Authors:  H Weber
Journal:  J Oslo City Hosp       Date:  1980-05

5.  Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?

Authors:  D L Douglas; T Duckworth; J A Kanis; A A Jefferson; T J Martin; R G Russell
Journal:  J Bone Joint Surg Br       Date:  1981

6.  Calcitonin treatment in lumbar spinal stenosis: clinical observations.

Authors:  A Eskola; H Alaranta; T Pohjolainen; J Soini; K Tallroth; P Slätis
Journal:  Calcif Tissue Int       Date:  1989-12       Impact factor: 4.333

7.  Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.

Authors:  R Lahtinen; M Laakso; I Palva; P Virkkunen; I Elomaa
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

8.  Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

Authors:  J A Kanis; O Johnell; B Gullberg; E Allander; G Dilşen; C Gennari; A A Lopes Vaz; G P Lyritis; G Mazzuoli; L Miravet
Journal:  BMJ       Date:  1992-11-07

9.  Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and predictors of response.

Authors:  N G Ward
Journal:  Spine (Phila Pa 1976)       Date:  1986-09       Impact factor: 3.468

10.  How many days of bed rest for acute low back pain? A randomized clinical trial.

Authors:  R A Deyo; A K Diehl; M Rosenthal
Journal:  N Engl J Med       Date:  1986-10-23       Impact factor: 91.245

View more
  3 in total

Review 1.  Conservative management of osteoporotic vertebral fractures: an update.

Authors:  A Slavici; M Rauschmann; C Fleege
Journal:  Eur J Trauma Emerg Surg       Date:  2016-12-26       Impact factor: 3.693

Review 2.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

Review 3.  Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Authors:  Juergen Braun; Joachim Sieper
Journal:  Arthritis Res       Date:  2002-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.